| CAS NO: | 1890169-95-5 |
| 包装 | 价格(元) |
| 10 mM * 1 mL in DMSO | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 500mg | 电议 |
| 生物活性 | UPGL00004 is a potent allostericglutaminaseC(GAC)inhibitor (IC50=29 nM;Kd=27 nM). UPGL00004 strongly inhibits the proliferation of highly aggressive triple-negative breastcancercell lines[1]. | ||||||||||||||||
| IC50& Target | IC50: 29 nM (Glutaminase C)[1] | ||||||||||||||||
| 体外研究 (In Vitro) | UPGL00004 inhibits MDA-MB-231, HS578T and TSE cells with IC50s of 70, 129, and 262 nM, respectively[1]. | ||||||||||||||||
| 体内研究 (In Vivo) | The combination of UPGL00004 (1 mg/kg body weight) and Bevacizumab (2.5 mg/kg body weight) via intraperitoneal injection completely prevent any detectable increase in tumor size in a triple-negative breast cancer patient-derived tumor graft model[1]. | ||||||||||||||||
| 分子量 | 534.66 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C25H26N8O2S2 | ||||||||||||||||
| CAS 号 | 1890169-95-5 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 125 mg/mL(233.79 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
